Article

PBA finds women more susceptible to eye disease than men

Women are diagnosed with eye diseases such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy more than men.

Chicago-Women are diagnosed with eye diseases such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy more than men. Not only have the numbers of age-related eye disease increased, women are still more affected than men, according to a report from Prevent Blindness America (PBA).

Of the more than 3.6 million Americans aged 40 and older who suffer from visual impairment, 2.3 million are women.

"Some may be under the impression that losing vision is just a simple part of the aging process but these numbers include many women in their 40s," said Daniel D. Garrett, senior vice president of PBA. "It's never too early to start caring for our eyes, and we strongly encourage women to make eye health a priority for themselves and their families today."

PBA suggests to all Americans that they make an eye appointment immediately if they experience the following symptoms:

  •  Unusual trouble adjusting to dark rooms;

  • Difficulty focusing on near or distant objects;

  •  Squinting or blinking due to unusual sensitivity to light or glare;

  •  Change in color of iris;

  •  Red-rimmed, encrusted or swollen lids;

  • Recurrent pain in or around eyes;

  • Double vision;

  • Dark spot at the center of viewing;

  • Lines and edges appear distorted or wavy;

  • Excess tearing or "watery eyes";

  • Dry eyes with itching or burning; and

  • Seeing spots or ghost-like images.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.